[Angiotensin II receptor antagonists].
Bornkessel
B
B
D000595:Amino Acid Sequence; D000804:Angiotensin II / Q000235:genetics / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D019808:Losartan; D008969:Molecular Sequence Data; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D011945:Receptors, Angiotensin / Q000235:genetics / Q000502:physiology; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D012504:Saralasin / Q000235:genetics; D013777:Tetrazoles / Q000009:adverse effects / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D011725:Pyridines; D011945:Receptors, Angiotensin; D013777:Tetrazoles; D000804:Angiotensin II; C066253:PD 123177; D012504:Saralasin; D019808:Losartan